Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia

American Journal of Cardiology

Volumn 87, Issue 1, 2001, Pages 44-48

  Frost, Robert J A ^a   Otto, Carsten ^a   Geiss, H Christian ^a   Schwandt, Peter ^a   Parhofer, Klaus G ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; FENOFIBRATE; FIBRINOGEN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLOOD RHEOLOGY; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DRUG EFFECT; ERYTHROCYTE AGGREGATION; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMA VISCOSITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TISSUE DISTRIBUTION;

AGED; ANTICHOLESTEREMIC AGENTS; ANTILIPEMIC AGENTS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMORHEOLOGY; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; PROCETOFEN; PROSPECTIVE STUDIES; PYRROLES; STATISTICS, NONPARAMETRIC;

EID: 0035191701     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)01270-4     Document Type: Article

References (22)

1. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
2. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
3. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
4. New haemorheological techniques for the routine laboratory
5. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol
6. Influence of LDL-Apheresis on LDL-subtypes in patients with coronary heart disease and severe hyperlipoproteinemia
7. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum
8. Variations in oxidative susceptibility among 6 low density lipoprotein subfractions of differing density and particle size
9. Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclass patterns
10. Clinical lipidology at the end of the millennium
11. Triglyceride concentration and ischaemic heart disease. An eight year follow-up in the Copenhagen Male Study
12. Lipid intervention trials in diabetes
13. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apoB production in miniature pigs
14. A multicenter double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia
15. Action of atorvastatin in combined hyperlipidemia - Preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles
16. Mechanism of action of fibrates on lipid and lipoprotein metabolism
17. Fibrates, dyslipoproteinemia and cardiovascular disease
18. Composition of human low density lipoprotein: Effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein
19. Statins do more than just lower cholesterol
20. More on atorvastatin and fibrinogen
21. Fenofibrate decreases plasma fibrinogen, improves lipid profile and reduces uricemia
22. Blood viscosity: Influence of erythrocyte aggregation